Professional Publications

Rakova, J.; Truxova, I.; Holicek, P.; Salek, C.; Hensler, M.; Kasikova, L.; Pasulka J.; Holubova, M.; Kovar, M.; Lysak, D.; Kline, J.P.; Racil, Z.; Galluzzi, L.; Spisek, R.; Fucikova, J.

TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients

[year of publication 2021, impact factor 8.110 ]

Kuželová, K.; Brodská, B.; Marková, J.; Petráčková, M.; Schetelig, J.; Ransdorfová, Š.; Gašová, Z.; Šálek, C.

NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia

[year of publication 2022, impact factor 8.110 ]

Jarolim, P.; Palek, J.; Rubin, H.L.; Prchal, J.; Korsgren, C.; Cohen, C.M.

Band 3 Tuscaloosa : Pro327 -> Arg327 substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2

[year of publication 2006, impact factor 8.061]

Jarolim, P.; Rubin, H.L.; Zhai, S.; Sahr, K.E.; Liu, S.C.; Mueller, T.J.; Palek, J.

Band 3 Memphis : a widespread polymorphism with abnormal electrophoretic mobility of erythrocyte band 3 protein caused by substitution AAG -> GAG (Lys -> Glu) in codon 56

[year of publication 2006, impact factor 8.061]

Cermak, J.; Key, N.S.; Bach, R.R.; Balla, J.; Jacob, H.S.; Vercellotti, G.M.

C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor

[year of publication 2006, impact factor 8.061]

Lukas, J.; Bartkova, J.; Welcker, M.; Petersen, O.W.; Peters, G.; Strauss, M.; Bartek, J.

Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types

[year of publication 2006, impact factor 7.991]

Bartkova, J.; Lukas, J.; Strauss, M.; Bartek, J.

Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis

[year of publication 2006, impact factor 7.991]

Viladiu, P.; Bosch, F.X.; Castellsagué, X.; Muňoz, N.; Escriba, J.M.; Hamšíková, E.; Hofmannová, V.; Guerrero, E.; Izquierdo, A.; Vonka, V.

Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2 and E7 peptides as predictors of survival in patients with squamous cell cervical cancer

[year of publication 2006, impact factor 7.878]

Radziwon, A.; Bhangu, S.K.; Fernandes, S.; Cortez-Jugo, C.; De Rose, R.; Dyett, B.; Wojnilowicz, M.; Laznickova, P.; Fric, J.; et al.

Triggering the nanophase separation of albumin through multivalent binding to glycogen for drug delivery in 2D and 3D multicellular constructs

[year of publication 2022, impact factor 7.790 ]

Rohde, M.; Warthoe, P.; Gjetting, T.; Lukas, J.; Bartek, J.; Strauss, M.

The retinoblastoma protein modulates expression of genes coding for diverse classes of proteins including components of the extracellular matrix

[year of publication 2006, impact factor 7.727]

Welcker, M.; Lukas, J.; Strauss, M.; Bartek, J.

Enhanced protein stability : a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells

[year of publication 2006, impact factor 7.727]

Alvarez-Larrán, A.; Pereira, A.; Guglielmelli, P.; Hernández-Boluda, J.C.; Arellano-Rodrigo, E.; Ferrer-Marín, F.; Samah, A.; Griesshammer, M.; Kerguelen, A.; Andreasson, B.; Burgaleta, C.; Schwarz, J.; García-Gutiérrez, V.; Ayala, R.; Barba, P.; Gómez-Casares, M.T.; Paoli, C.; Drexler, B.; Zweegman, S.; McMullin, M.F.; Samuelsson, J.; Harrison, C.; Cervantes, F.; Vannucchi, A.M.; Besses, C.

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

[year of publication 2016, impact factor 7.702 ]

Hruba, P.; Brabcova, I.; Gueler, F.; Krejcik, Z.; Stranecky, V.; Svobodova, E.; Maluskova, J.; Gwinner, W.; Honsova, E.; Lodererova, A.; Oberbauer, R.; Zachoval, R.; Viklicky, O.

Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes

[year of publication 2015, impact factor 7.683 ]

Vonka, V.; Humlova, Z.; Klamova, H.; Kujovska-Krcmova, L.; Petrackova, M.; Hamsikova, E.; Krmencikova-Fliegl, M.; Duskova, M.; Roth, Z.

Kynurenine and uric acid levels in chronic myeloid leukemia patients

[year of publication 2014, impact factor 7.644 ]

Partlová, S.; Bouček, J.; Kloudová, K.; Lukešová, E.; Zábrodský, M.; Grega, M.; Fučíková, J.; Truxová, I.; Tachezy, R.; Špíšek, R.; Fialová, A.

Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma

[year of publication 2014, impact factor 7.644 ]

de Swart, L.; Reiniers, C.; Bagguley, T.; van Marrewijk, C.; Bowen, D.; Hellström-Lindberg, E.; Tatic, A.; Symeonidis, A.; Huls, G.; Cermak, J.; et al.

Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes

[year of publication 2018, impact factor 7.570 ]

Srutova, K.; Curik, N.; Burda, P.; Savvulidi, F.; Silvestri, G.; Trotta, R.; Klamova, H.; Pecherkova, P.; Sovova, Z.; Koblihova, J.; Stopka, T.; Perrotti, D.; Machova Polakova, K.

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia

[year of publication 2018, impact factor 7.570 ]

Zhang, S.; Sroller, V.; Zanwar, P.; Chen, C.J.; Halvorson, S.J.; Ajami, N.J.; Hecksel, C.W.; Swain, J.L.; Wong, C.; Sullivan, C.S.; Butel, J.S.

Viral microRNA effects on pathogenesis of polyomavirus SV40 infections in Syrian golden hamsters

[year of publication 2014, impact factor 7.562 ]

Hruba, P.; Krejcik, Z.; Dostalova Merkerova, M.; et al.

Molecular fingerprints of borderline changes in kidney allografts are influenced by donor category

[year of publication 2020, impact factor 7.561 ]

Hortová-Kohoutková, M.; De Zuani, M.; Lázničková, P.; Bendíčková, K.; Mrkva, O.; Andrejčinová, I.; Mýtniková, A.; Polanský, O.; Kočí, K.; Tomášková, V.; Šrámek, V.; Helán, M.; Frič, J.

Polymorphonuclear cells show features of dysfunctional activation during fatal sepsis

[year of publication 2022, impact factor 7.561 ]